Business
Trials of AstraZeneca COVID vaccine resuming after ‘wake up call’ – Sydney Morning Herald
British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.
The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.
AstraZeneca, based in Cambridge, said it could not disclose further medical information.
“The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” AstraZeneca said.
It …
-
Noosa News17 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News19 hours agoConcerns over WHO pandemic agreement
-
Business17 hours ago3 unstoppable ASX ETFs to buy and hold for 10 years
-
General16 hours agoSouth Australian Tim Looker becomes a lawyer on 74th birthday